Analysis of IGF-1, depending on the concentrations of its serum level of IGF-1 with repeat CA in the P1 promoter region of the IGF-1 gene for subjects with or without CA19-19 repeats, demonstrated statistically significant higher levels in the H-SIL and ICC groups, compared with others. Here, IGF1 is linked to intrahepatic cholangiocarcinoma.